Levetiracetam
- Product NDC
- 57297-112
- 11-digit product format
- 572970112
- Labeler code
- 57297
- Product ID
- 57297-112_93623b6f-02f0-4b27-bd37-b2bc3f354c91
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levetiracetam
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- LUPIN LIMITED
- Application
- ANDA078154
- Marketing category
- ANDA
- Marketing start
- 2009-01-01
- Marketing end
- 0000-00-00
- Substance
- LEVETIRACETAM
- Active strength
- 250 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57297-112-02 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-4b73-f424-e053-dadaa90a57ce | f7a0cb0f-a535-4d19-b05e-690822fa8276 |
| 57297-112-09 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-4b73-f424-e053-dadaa90a57ce | f7a0cb0f-a535-4d19-b05e-690822fa8276 |
| 57297-112-16 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-4b73-f424-e053-dadaa90a57ce | f7a0cb0f-a535-4d19-b05e-690822fa8276 |
| 57297-112-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4b73-f424-e053-dadaa90a57ce | f7a0cb0f-a535-4d19-b05e-690822fa8276 |
| 57297-112-09 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4b73-f424-e053-dadaa90a57ce | f7a0cb0f-a535-4d19-b05e-690822fa8276 |
| 57297-112-16 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4b73-f424-e053-dadaa90a57ce | f7a0cb0f-a535-4d19-b05e-690822fa8276 |